summary of these studies which are reviewed in considerable detail. The association of risk factors for coronary heart disease (C.H.D.) and atherosclerotic lesions, derived from data from the International Atherosclerosis Project, indicate that the lesions are shown to be related to serum cholesterol and dietary fat when comparing populations. However, insufficient data are available to confirm such association on an individual basis within a population. Lesions were greater in hypertensive and diabetic individuals and in heavy cigarette smokers. No consistent association of atherosclerotic lesions were observed with physical activity or obesity.
In another study a faster resting heart rate was reported to be an independent coronary risk factor. Nutrition Toxic factors in nutrients such as peanut and coconut oil have been indicated and the increased incidence of cardiovascular disease in areas with soft water suggests a possible protective role of the minerals present in hard water supplies. Another study suggests a composition of diets for reducing blood cholesterol and maintaining its low level. This diet must be low in myristic and palmitic acids, it should contain less than 350 mg cholesterol and be relatively rich in polyunsaturated fatty acids.
A statistical link between raised blood sugar levels and incidence of atherosclerotic arterial disease has been indicated. The nature of the association is less clear. A direct effect of raised blood sugar may involve localised osmotic damage to the arterial intima due to accumulation of non-diffusible sorbitol. Drugs The effects of clofibrate and the possible mechanisms of its action are reviewed. The effects show a decrease in plasma lipoprotein levels, fibrinogen levels and platelet adhesiveness and an increase in platelet survival, body weight and liver weight. Numerous mechanisms of drug action have been suggested but the mechanism is still not completely understood. The effect of non absorbant hypolipidaemic agents such as cholystyramine, neomycin or DEAE Sephadex on cholesterol metabolism in man are also reviewed.
Increased levels of free fatty acids and triglycerides are implicated in the pathogenesis of atherosclerosis and effective chemotherapy against these high levels appears to be promising.
A review of drugs affecting platelet function is presented and aspirin has been cited as a potential agent in preventing the formation of platelet thrombi. Various chemically useful drugs and their modes of interaction with norepinepherine storage mechanisms are also reviewed.
The design of primary and secondary preventive trials have been reviewed in some detail and it has been stressed that the highest exercise of scientific 63 judgment is called for in such trials since the possibilities of independent repetition are severely limited by costs and the time involved. An account is given of progress of a preliminary preventive trial using clofibrate to observe its effect on the incidence of heart disease by reducing elevated serum lipids in healthy men. Ten thousand men aged 30-59 have been admitted to the study which is based in Edinburgh, Prague and Budapest. The degree of reduction of elevated serum lipids is regarded as satisfactory and no side effects of consequence have occurred.
Some aspects of the progress in drug trials of secondary prevention with particular reference to the coronary drug project has been revealed by a very large panel of experts under the authorship of 'the Coronary Drug Project Research Group'.
Program planning for control of atherosclerosis has also been aired and the view expressed that a definitive preventive trial sponsored by the American Government appears to be absolutely essential.
J May, 1970 . Various experimental approaches to fertility control were discussed as well as recent advances in methods of stimulating ovarian function. The early chapters describe the oral contraceptives based on oestrogens and progesterone and they are followed by contributions on non-steroidal contraceptives, intrauterine devices and by reviews on the factors influencing fertilisation and implantation and on immunological aspects of reproduction. Representatives of W.H.O. discussed problems related to induced abortions and the various health aspects of the use of fertility controlling agents. Each contribution is followed by a discussion which often adds to the interest of the chapter.
The first paper by Egon Diczfalusy sets a predictably high standard which is generally maintained throughout the book. With his usual clarity and awareness of existing problems Professor Diczfalusy reviews the chemistry of the steroids used as oral contraceptives and discusses their metabolism and mode of action. In developing new contraceptives it is hazardous to extrapolate to the human observations made on other species but this has to be done. There is great public interest in any new product and it is widely expected that the drug will exhibit its desired effect over long periods with never any side effect. Then when products are developed which are virtually 100% effective a moral conflict arises when a new compound requires testing-a compound of unknown and possibly lower effectiveness. In early work with oral contraceptives it was usual to overdose to ensure no pregnancies. This approach is most likely to encourage side reactions: nowadays there is a tendency to start with lower doses and offer abortion on demand in the case of failures.
Considerably less work has been done on the 'pill' for males. Dr. H. Jackson considers that at present it seems doubtful that suppression of the spermatogenic process could feature as an acceptable method of fertility control although for the biological control of certain pests, parasites,etc. it is a valuable tool. He reviewed some interesting compounds such as the esters of methane suIphonic acid, the chlorhydrins and a compound, hexamethylphosphoramide, which becomes ineffective on losing only one of its six methyl groups. Non-steroidal compounds used in the female were described by Dr. N. Wiqvist: these include the prostaglandins, the subject of another Nobel Symposium in 1967 and of numerous other publications.
The importance of trace metals such as copper and zinc in fertility has been recognised for some time. Dr. Zipper presented applications such as the use of copper-containing intra-uterine devices and in the discussion which followed there were data given on the occurrence of trace metals in the human endometrium.
Immunology offers an attractive approach to fertility control. An authority in this field, Dr. R. Mancini, reviewed the extensive research done on the antigens in the testis, semen and spermatozoa. Immune phenomena which appear to be involved in cases of male sterility might be used in future for the induction of sterilityeither in the male or in the female.
Another chapter of biochemical interest, by Dr. P. Srivastava, is concerned with the capacitation factors first observed some 20 years ago. It was noted that spermatozoa of rabbits and rats must reside in the female reproductive tract for a period of time to acquire the capacity to fertilise the ovum. A decapacitation factor has also been recognised as a constituent of the male reproductive tract, particularly of seminal plasma, which reverses the process of capacitation rendering spermatozoa incapable of fertilisation. This factor has been purified by gel filtration but it is clear that a great deal more work is required to establish its nature.
These chapters and another 12 that are equally good, make a notable contribution to the literature on what must be the greatest problem that man has to face in the next few decades.
W. R. Butt
Inherited Disorders of Sulphur MetaboUsm. N. A. J. CARSON and D. N. RAINE (eds.), Churchill-Livingstone Ltd., Edinburgh, 1971. Pp. 312. £4·50. This 8th Symposium of the Society for the Study of Inborn Errors of Metabolism, held in Belfast, 1970 , was devoted to recent observations and ideas on biochemical disorders in one metabolic pathway only, i.e. to the handling of methionine-homocysteine-cystathionine-cyst(e)ine. It was hoped by the organisers that such a limitation should give an 'updated knowledge of current research into all aspects of abnormalities known in this pathway'. To a large extent this attempt has proven successful. In extensive contributions much valuable information was given from laboratories actively engaged in the detailed study of patients with disorders resulting in increased concentrations of one or more of the metabolites in question in urine, serum or tissue. At the present state of affairs such presentations are necessary, inter alia to delineate clinical entities for further study.
The goal of the Society is 'to promote exchange of ideas between workers in different disciplines who are interested in any aspect of inborn metabolic disorders'. It appears that with the present symposium a further step is taken toward the fulfilment of this aim by including introductory lectures of specialists in the basic biochemistry of the sulphur compounds. In my opinion, however, the composition of the symposium is still somewhat out of balance when keeping the above aim in mind. In particular, the interdisciplinary problems under investigation should justify more contributions from the basic disciplines of biochemistry, enzymology and genetics.
L. Eldjarn Progress in Medicinal Chemistry, Vol. 7, Part 2. G. P. ELLIS and G. B. WEST (eds.), Butterworth & Co., London, 1970. Pp. 341. £3·30. Parts 1 and 2 available in a single volume £8·00.
The second part of Vol. 7 of Progress in Medicinal Chemistry comprises three essays. In the first Professor Peart briefly discusses some of the disorders for which more effective therapeutic agents are required. In the second A. F. Casey discusses recent progress in the evaluation of analgesic drugs and their antagonists, building upon two earlier articles in this series, written in collaboration with A. H. Beckett. He considers morphine and its derivatives, thebaines, morphinans, phenylpiperidines and pyrrolidones together with several types of analgesic antagonist. In conclusion he discusses critically hypothetical modes of drug action based on the stereochemical characteristics of their molecular structure. In the third essay C. C. Cheng and Barbara Roth continue their survey of some pyrimidines of
